MedPath
TGA Approval

BRINTELLIX vortioxetine (as hydrobromide) 5 mg film-coated tablet blister pack (203986)

203986

BRINTELLIX vortioxetine (as hydrobromide) 5 mg film-coated tablet blister pack

Lundbeck Australia Pty Ltd

March 31, 2014

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-CMI-01012-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-PI-01635-1

Active Ingredients

vortioxetine hydrobromide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BRINTELLIX vortioxetine (as hydrobromide) 5 mg film-coated tablet blister pack (203986) - TGA 批准文号 | MedPath